Publication | Closed Access

Lack of association between SLCO1B1 polymorphism and the lipid-lowering effects of atorvastatin and simvastatin in Chinese individuals

Metabolic SyndromeLipid-lowering EffectsLipid DisorderCardiovascular EpidemiologyCardiovascular DiseaseGenetic EpidemiologyHuman PolymorphismSlco1b1 PolymorphismHyperlipidemiaDyslipidemiaLipoprotein MetabolismPublic HealthEpidemiologyChinese Individuals